Navigation Links
PAREXEL Reaches Agreement To Acquire ClinPhone
Date:6/13/2008

Combined Capabilities to Create One of the Industry's Largest eClinical

Technology Offerings

BOSTON, June 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services organization, today announced that the Boards of PAREXEL International and ClinPhone plc, a company traded on the London Stock Exchange, ("ClinPhone") have reached agreement on the terms of a recommended proposal whereby a wholly owned subsidiary of PAREXEL will acquire the entire issued and to be issued ordinary share capital of ClinPhone. With headquarters in Nottingham, United Kingdom, ClinPhone is one of the world's leading clinical technology organizations.

The acquisition is based on the offer price of 135 pence in cash for each ClinPhone share. The offer price represents a premium of 86 percent to the ClinPhone share price on the London Stock Exchange of 72.5 pence on February 14, 2008, the last business day before the start of the "Offer Period" commencing on February 15, 2008 and ending on the date on which the acquisition becomes effective in accordance with its terms. The acquisition values the entire issued ordinary share capital of ClinPhone at approximately 91 million Pounds Sterling (GBP), or approximately $182 million U.S. Dollars (USD). PAREXEL has arranged a $300 million USD facility with JPMorgan Chase Bank, N.A. and Keybank National Association in order to fund the acquisition and costs related to the acquisition, and to refinance the existing debt of ClinPhone and PAREXEL. The acquisition is expected to close in the first quarter of PAREXEL's Fiscal Year 2009, or by September 30, 2008.

Josef von Rickenbach, Chairman and Chief Executive Officer o
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
2. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
3. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
4. PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
5. PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
6. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
7. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
8. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
10. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
11. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Pittsburgh, PA (PRWEB) January 15, 2014 The ... Company, publisher of Food Safety Tech , an e-Journal ... has signed an agreement for the second year for the ... with Pittcon 2014. The partnership provides that the registration fee ... will also include unlimited week long admission to the Pittcon ...
(Date:1/15/2014)... , Jan. 15, 2014 ­ RedBrick Health ... behavior change technology, today announces that EmblemHealth , ... and wellness company, is now providing the RedBrick Compass ... coaching program, to all of its members. EmblemHealth is ... weave these interlocking components of the RedBrick 5 advanced ...
(Date:1/15/2014)... NY (PRWEB) January 15, 2014 The ... can cause a major disease. One of these latent ... of these diseases is rheumatoid arthritis (RA). Rheumatoid arthritis ... body’s joints. As predicted by the theory, a study ... DNA in their bodies (1). , What is ...
(Date:1/15/2014)... -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic ... caused by drug-resistant bacteria. Under the terms of ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... , , , ... (Nasdaq: CALP ), a leading provider of tools ... introduced the IVIS Lumina XR in vivo imaging system, the ... system combines highly sensitive bioluminescence and fluorescence molecular optical imaging ...
... , , PHILADELPHIA, Sept. ... Professionals Society) conference in booth #607, Prolifiq announced software ... increasingly complex web of regulations governing sales communication. Prolifiq ... companies--is used to organize, send and track approved digital ...
... ... patients. Daniel Neal from Palm Springs, CA, gains the ability and confidence to put his ... ... improves walking for Parkinson,s disease patients. Daniel Neal from Palm Springs, CA, gains the ability ...
Cached Biology Technology:Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray 2Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray 3Prolifiq Announces Software for Life Sciences: Accelerates Sales, Embeds Adherence to Regulatory Compliance, Incorporates Good Promotional Practices 2Prolifiq Announces Software for Life Sciences: Accelerates Sales, Embeds Adherence to Regulatory Compliance, Incorporates Good Promotional Practices 3New Superman Glasses for Parkinson's Disease Improve Walking and Quality of Life 2
(Date:4/15/2014)... Connecticut, a Puerto Rican community is creating a tropical ... authentic it has caught the attention of scientists. David ... (University of Connecticut) took a close look at the ... and uncovered evidence that gives new meaning to a ... home is in the kitchen. , "Culinary preferences tell ...
(Date:4/15/2014)... professor of mechanical engineering at Worcester Polytechnic ... university,s Integrative Materials Design Center (iMdc), recently ... leading engineering societies. , At its annual ... association of more than 138,000 engineers and ... and commercial vehicle industries, presented Lados with ...
(Date:4/15/2014)... study the deadliest infectious diseases recognized the contributions of ... the University of Texas Medical Branch, with a Lifetime ... Filoviruses. The filoviruses include Ebola and Marburg viruses that ... infected. The current outbreak of Ebola virus raging in ... far. , "This award represents the culmination of ...
Breaking Biology News(10 mins):The human food connection: A new study reveals more about our relationship to food 2The human food connection: A new study reveals more about our relationship to food 3WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 2WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 3WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 4WPI's Diana Lados honored by SAE International and Minerals, Metals, and Materials Society 5International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3
... In recent years, researchers have worked to develop a ... tumors. Cancer vaccines are not intended to prevent cancer; ... preexisting tumors. Unlike traditional chemotherapy, vaccines have relatively low ... To date, these vaccines have rarely been designed to ...
... physics to show how our circadian clocks manage to ... , In an article appearing March 13 in the ... Federale de Lausanne demonstrate that the stability of cellular ... studies in families affected by advanced sleep phase syndrome. ...
... critical role in the development of the placenta, the organ ... her fetus during pregnancy, and perhaps in miscarriages. , ... (Rb) gene in mice. In humans, this gene, when mutated, ... called retinoblastoma. Two decades ago, it was identified as the ...
Cached Biology News:Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine 2Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine 3Keeping the body in sync -- The stability of cellular clocks 2Tumor-suppressor gene is critical for placenta development 2Tumor-suppressor gene is critical for placenta development 3
Request Info...
Candida (IgG) -Ab EIA Sample Size: 5 l...
... Oxidized LDL (Competitive) EIA Principle: The ... monoclonal antibody 4E6. Oxidized LDL in the sample ... bound to the microtiter well for the binding ... washing st Sample Size: 25 l ...
... RNase III, used with its manganese-containing reaction ... heterogeneous mix of short (1825 bp) interfering ... mammalian cells. 1.3 units (1 l) of ... 1 g of dsRNA into siRNA suitable ...
Biology Products: